Jiangxi Aifeimu Technology Co.,Ltd with Dapoxetine series, Atorvastatin Calcium, Fluvastatin Sodium, Rosuvastatin Calcium, Pitavastatin Calcium, dapagliflozin, empagliflozin and their intermediates as main products. Based on top technologies, Aifeimu has adopted advanced quality control system from overseas to put strict control on material purchase, production and sales. Advanced testing instruments and perfect testing methods are also employed to ensure the products are in accordance with the USP/EP standards.
more >
Year of Establishment:
2004
Total Assets(USD):
2,000,000 to 2,999,999
Total Number of Staff:
70 to 79
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
2,000,000 to 2,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: